{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:31:50Z","timestamp":1793309510054,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 114-2221-E-155-028-MY3"],"award-info":[{"award-number":["NSTC 114-2221-E-155-028-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2221-E-155-020-MY3"],"award-info":[{"award-number":["NSTC 112-2221-E-155-020-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154567","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:46:43Z","timestamp":1788950803000},"page":"154567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NeoGen-BC: A synergistic framework combining generative protein language models and multi-window deep learning for designing shared neoantigens in breast cancer"],"prefix":"10.1016","volume":"836","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5239-2075","authenticated-orcid":false,"given":"Van The","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Peter Timothy","family":"Yuune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-I","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154567_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1321654","article-title":"Heterogeneity in breast cancer: clinical and therapeutic implications","volume":"14","author":"Carlino","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib3","first-page":"20","article-title":"Genetic heterogeneity in breast cancer: implications","volume":"2","author":"Mohamed","year":"2024","journal-title":"Elite J. Health Sci."},{"key":"10.1016\/j.bbrc.2026.154567_bib4","doi-asserted-by":"crossref","DOI":"10.1177\/11782234251355663","article-title":"Recent insights into breast cancer: molecular pathways, epigenetic regulation, and emerging targeted therapies","volume":"19","author":"Maqsood","year":"2025","journal-title":"Breast Cancer Basic Clin. Res."},{"issue":"23","key":"10.1016\/j.bbrc.2026.154567_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313165","article-title":"The genomic and biologic landscapes of breast cancer and racial differences","volume":"25","author":"Galappaththi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154567_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102861","article-title":"PI3K\/AKT\/mTOR inhibitors for hormone receptor-positive advanced breast cancer","volume":"132","author":"Hao","year":"2025","journal-title":"Cancer Treat Rev."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154567_bib7","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/jcm13071873","article-title":"Hormone receptor-positive\/HER2-Positive Breast Cancer: hormone Therapy and Anti-HER2 treatment: an update on treatment strategies","volume":"13","author":"Tommasi","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbrc.2026.154567_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102670","article-title":"Current and emerging treatment approaches for hormone receptor-positive\/human epidermal growth factor receptor 2-negative metastatic breast cancer","volume":"123","author":"Jhaveri","year":"2024","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41523-024-00680-0","article-title":"Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy","volume":"10","author":"Tesch","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.bbrc.2026.154567_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Oncol."},{"issue":"17","key":"10.1016\/j.bbrc.2026.154567_bib11","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3390\/diagnostics14171875","article-title":"Triple-negative breast cancer: molecular particularities still a challenge","volume":"14","author":"Varzaru","year":"2024","journal-title":"Diagnostics"},{"issue":"21","key":"10.1016\/j.bbrc.2026.154567_bib12","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41523-025-00729-8","article-title":"Clinico-pathological factors predicting pathological response in early triple-negative breast cancer","volume":"11","author":"Helal","year":"2025","journal-title":"NPJ Breast Cancer"},{"issue":"15","key":"10.1016\/j.bbrc.2026.154567_bib14","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.3390\/ijms22157812","article-title":"Oral selective estrogen receptor degraders (SERDs) as a novel breast cancer therapy: present and future from a clinical perspective","volume":"22","author":"Hernando","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154567_bib15","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.2147\/DDDT.S380925","article-title":"Oral selective estrogen receptor degraders (SERDs) in breast cancer: advances, challenges, and current status","author":"Downton","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbrc.2026.154567_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176424","article-title":"Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer","volume":"969","author":"Guglielmi","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.bbrc.2026.154567_bib17","doi-asserted-by":"crossref","first-page":"15094","DOI":"10.1021\/acs.jmedchem.0c00913","article-title":"Selective estrogen receptor degraders (SERDs): a promising strategy for estrogen receptor positive endocrine-resistant breast cancer","volume":"63","author":"Lu","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-023-00373-7","article-title":"Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment","volume":"12","author":"Yan","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.bbrc.2026.154567_bib19","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.cell.2023.06.020","article-title":"Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy","volume":"186","author":"Dolton","year":"2023","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154567_bib20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41581-023-00700-5","article-title":"Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens","volume":"19","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154567_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/imm.13643","article-title":"Development of novel self\u2010assembled vaccines based on tumour\u2010specific antigenic peptide and TLR2 agonist for effective breast cancer immunotherapy via activating Cd8+ T cells and enhancing their function","volume":"169","author":"Shi","year":"2023","journal-title":"Immunology"},{"issue":"50","key":"10.1016\/j.bbrc.2026.154567_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202314588","article-title":"T cell antigen recognition and discrimination by electrochemiluminescence imaging","volume":"62","author":"Yan","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154567_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41571-020-00460-2","article-title":"Advances in the development of personalized neoantigen-based therapeutic cancer vaccines","volume":"18","author":"Blass","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154567_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/or.2025.1541326","article-title":"Advancements and challenges in personalized neoantigen-based cancer vaccines","volume":"19","author":"Singh","year":"2025","journal-title":"Oncol. Rev."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.69709\/CIConnect.2024.194763","article-title":"Neoantigen-based cancer vaccines: current innovations, challenges and future directions in personalized immunotherapy","volume":"1","author":"Ahmed","year":"2024","journal-title":"Cancer Immunol Connect"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib26","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1186\/s12885-025-13992-6","article-title":"HLA class II-restricted T cell epitopes in public neoantigens of ESR1 and PIK3CA in breast cancer","volume":"25","author":"Ando","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166740","article-title":"Breast cancer immunopeptidomes contain numerous shared tumor antigens","volume":"134","author":"Kina","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib28","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12967-025-06478-3","article-title":"Shared neoantigens' atlas for off-the-shelf cancer vaccine development","volume":"23","author":"Mauriello","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154567_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fbinf.2023.1207380","article-title":"Improved prediction of MHC-peptide binding using protein language models","volume":"3","author":"Hashemi","year":"2023","journal-title":"Frontiers in Bioinformatics"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad785","article-title":"RPEMHC: improved prediction of MHC\u2013peptide binding affinity by a deep learning approach based on residue\u2013residue pair encoding","volume":"40","author":"Wang","year":"2024","journal-title":"Bioinformatics"},{"issue":"Supplement_1","key":"10.1016\/j.bbrc.2026.154567_bib31","doi-asserted-by":"crossref","first-page":"i220","DOI":"10.1093\/bioinformatics\/btac225","article-title":"DeepMHCII: a novel binding core-aware deep interaction model for accurate MHC-II peptide binding affinity prediction","volume":"38","author":"You","year":"2022","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12864-023-09900-6","article-title":"Structure-aware deep model for MHC-II peptide binding affinity prediction","volume":"25","author":"Yu","year":"2024","journal-title":"BMC Genom."},{"issue":"9","key":"10.1016\/j.bbrc.2026.154567_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216697120","article-title":"Peptide-binding specificity prediction using fine-tuned protein structure prediction networks","volume":"120","author":"Motmaen","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"10.1016\/j.bbrc.2026.154567_bib34","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1093\/bioinformatics\/btab422","article-title":"BERTMHC: improved MHC\u2013peptide class II interaction prediction with transformer and multiple instance learning","volume":"37","author":"Cheng","year":"2021","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.bbrc.2026.154567_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2567.2010.03300.x","article-title":"Major histocompatibility complex class I binding predictions as a tool in epitope discovery","volume":"130","author":"Lundegaard","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2026.154567_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.136252","article-title":"DeepNeoAG: neoantigen epitope prediction from melanoma antigens using a synergistic deep learning model combining protein language models and multi-window scanning convolutional neural networks","volume":"281","author":"Chuang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154567_bib37","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1109\/TPAMI.2021.3095381","article-title":"Prottrans: toward understanding the language of life through self-supervised learning","volume":"44","author":"Elnaggar","year":"2021","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"issue":"6637","key":"10.1016\/j.bbrc.2026.154567_bib38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154567_bib39","article-title":"Evaluating protein transfer learning with TAPE","volume":"32","author":"Rao","year":"2019","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.bbrc.2026.154567_bib40","first-page":"9459","article-title":"Retrieval-augmented generation for knowledge-intensive nlp tasks","volume":"33","author":"Lewis","year":"2020","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.bbrc.2026.154567_bib41","series-title":"Active Retrieval Augmented Generation","first-page":"7969","author":"Jiang","year":"2023"},{"key":"10.1016\/j.bbrc.2026.154567_bib42","series-title":"Evaluation of retrieval-augmented Generation: a Survey","first-page":"102","author":"Yu","year":"2024"},{"key":"10.1016\/j.bbrc.2026.154567_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.109541","article-title":"ATP_mCNN: predicting ATP binding sites through pretrained language models and multi-window neural networks","volume":"185","author":"Le","year":"2025","journal-title":"Comput. Biol. Med."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154567_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70085","article-title":"NAD_MCNN: combining protein Language models and multiwindow convolutional neural Networks for Deacetylase NAD+ binding site prediction","volume":"105","author":"Le","year":"2025","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bbrc.2026.154567_bib45","first-page":"1","article-title":"DeepCR: predicting cytokine receptor proteins through pretrained language models and deep learning networks","author":"Le","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib46","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1038\/s41467-022-32007-7","article-title":"ProtGPT2 is a deep unsupervised language model for protein design","volume":"13","author":"Ferruz","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/life13010155","article-title":"A universal antigen-ranking method to design personalized vaccines targeting neoantigens against Melanoma","volume":"13","author":"Malaina","year":"2023","journal-title":"Life"},{"issue":"13","key":"10.1016\/j.bbrc.2026.154567_bib48","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/bioinformatics\/btl158","article-title":"Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences","volume":"22","author":"Li","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbrc.2026.154567_bib49","series-title":"Mathematical Principles in Bioinformatics","first-page":"115","article-title":"Convex hull principle and distinguishing proteins from arbitrary amino acid sequences","author":"Yau","year":"2023"},{"issue":"1","key":"10.1016\/j.bbrc.2026.154567_bib50","article-title":"Comparative evaluation of the prediction accuracy of AlphaFold and ESMFold for monomeric and dimeric proteins","volume":"8","author":"Mahtha","year":"2026","journal-title":"NAR Genom. Bioinf."},{"key":"10.1016\/j.bbrc.2026.154567_bib51","series-title":"Introduction to Transformers for NLP: with the Hugging Face Library and Models to Solve Problems","first-page":"51","article-title":"Hugging face","author":"Jain","year":"2022"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154567_bib52","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/prot.26652","article-title":"Random, de novo, and conserved proteins: how structure and disorder predictors perform differently","volume":"92","author":"Middendorf","year":"2024","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"7873","key":"10.1016\/j.bbrc.2026.154567_bib53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"nature"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26013318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:54:00Z","timestamp":1793307240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26013318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":53,"alternative-id":["S0006291X26013318"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154567","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NeoGen-BC: A synergistic framework combining generative protein language models and multi-window deep learning for designing shared neoantigens in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154567"}}